Paul Tudor Jones Alector, Inc. Transaction History
Tudor Investment Corp Et Al
- $19.2 Billion
- Q2 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Alector, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 20,337 shares of ALEC stock, worth $94,973. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,337Holding current value
$94,973% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ALEC
# of Institutions
165Shares Held
58.1MCall Options Held
57KPut Options Held
14.9K-
Black Rock Inc. New York, NY9.1MShares$42.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$24.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$21.6 Million0.69% of portfolio
-
Morgan Stanley New York, NY3.01MShares$14 Million0.0% of portfolio
-
State Street Corp Boston, MA2.79MShares$13 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $386M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...